- Home
- GRRR vs CMPS Comparison
GRRR vs CMPS Comparison
Compare GRRR & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- CMPS
- Stock Information
- Founded
- GRRR 2001
- CMPS 2020
- Country
- GRRR United Kingdom
- CMPS United Kingdom
- Employees
- GRRR N/A
- CMPS N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- GRRR Technology
- CMPS Health Care
- Exchange
- GRRR Nasdaq
- CMPS Nasdaq
- Market Cap
- GRRR 387.9M
- CMPS 364.9M
- IPO Year
- GRRR N/A
- CMPS 2020
- Fundamental
- Price
- GRRR $25.90
- CMPS $4.59
- Analyst Decision
- GRRR Buy
- CMPS Strong Buy
- Analyst Count
- GRRR 1
- CMPS 7
- Target Price
- GRRR $18.00
- CMPS $18.83
- AVG Volume (30 Days)
- GRRR 2.0M
- CMPS 1.7M
- Earning Date
- GRRR 06-18-2025
- CMPS 07-31-2025
- Dividend Yield
- GRRR N/A
- CMPS N/A
- EPS Growth
- GRRR N/A
- CMPS N/A
- EPS
- GRRR N/A
- CMPS N/A
- Revenue
- GRRR $84,196,961.00
- CMPS N/A
- Revenue This Year
- GRRR $36.59
- CMPS N/A
- Revenue Next Year
- GRRR $30.68
- CMPS N/A
- P/E Ratio
- GRRR N/A
- CMPS N/A
- Revenue Growth
- GRRR 19.91
- CMPS N/A
- 52 Week Low
- GRRR $2.09
- CMPS $2.49
- 52 Week High
- GRRR $44.15
- CMPS $8.54
- Technical
- Relative Strength Index (RSI)
- GRRR 67.95
- CMPS 59.49
- Support Level
- GRRR $18.14
- CMPS $4.33
- Resistance Level
- GRRR $20.34
- CMPS $5.15
- Average True Range (ATR)
- GRRR 2.06
- CMPS 0.38
- MACD
- GRRR 0.35
- CMPS -0.01
- Stochastic Oscillator
- GRRR 91.61
- CMPS 66.65
About GRRR Gorilla Technology Group Inc.
Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.